Citigroup
ISPC icon

Citigroup’s iSpecimen ISPC Stock Holding History

Citigroup’s Portfolio ISPC Stock Details ISPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2
Closed -$9K – 6429
2022
Q1 		$9K Buy
+2
New +$7.82K ﹤0.01% 5577

Other funds holding ISPC

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MSFS
Main Street Financial Solutions Newtown, Pennsylvania $1.34B AUM 19.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup's ISPC Position: Q2 2022 in Review

Citigroup sold out of iSpecimen (ISPC) in Q2 2022, closing a stake of 2 shares — an estimated $9K sold.

Citigroup first reported a position in ISPC in Q1 2022 and held it in 1 quarter. The position peaked at $9K in Q1 2022. 13 funds tracked by Wall St. Rank hold ISPC as of Q2 2022.

  • Citigroup reported no remaining iSpecimen position as of Q2 2022 after selling out during the quarter.
  • Citigroup sold 2 iSpecimen shares in Q2 2022, an estimated $9K.
  • Citigroup first reported a position in iSpecimen in Q1 2022 and held it in 1 quarter.
  • Citigroup's iSpecimen position peaked at $9K in Q1 2022.
  • 13 funds tracked by Wall St. Rank held iSpecimen as of Q2 2022.

Based on Citigroup's 13F filing for Q2 2022, filed 10 Aug 2022.